Clinical Autonomic Research

, Volume 15, Issue 1, pp 51–53 | Cite as

Pyridostigmine for treatment of neurogenic orthostatic hypertension

A follow-up survey study
  • Paola Sandroni
  • Tonette L. Opfer-Gehrking
  • Wolfgang Singer
  • Phillip A. Low
SHORT COMMUNICATION

Abstract

We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patients’ satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.

Key words

orthostatic hypotension pyridostigmine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Camilleri M, Malagelada JR, Stanghellini V, Fealey RD, Sheps SG (1985) Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology 88(6):1852–1859PubMedGoogle Scholar
  2. 2.
    Chobadian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D (1979) Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med 301(2):68–73CrossRefGoogle Scholar
  3. 3.
    Consensus statement (1996) The definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 519:1–10Google Scholar
  4. 4.
    Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure [erratum appears in Hypertension (2003) 43(4):e12]. Hypertension 42(2):136–142PubMedGoogle Scholar
  5. 5.
    Jacob G, Shannon JR, Black B, et al. (1997) Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 96(2):575–580PubMedGoogle Scholar
  6. 6.
    Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA (1997) Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group [erratum appears in JAMA (1997) 278(5):388]. JAMA 277(13):1046–1051CrossRefPubMedGoogle Scholar
  7. 7.
    Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I, Robertson D, Biaggioni I (1997) The hypertension of autonomic failure and its treatment. Hypertension 30(5):1062–1067PubMedGoogle Scholar
  8. 8.
    Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA (2003) Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension [see comment]. J Neurol Neurosurg Psychiatry 74(9):1294–1298PubMedGoogle Scholar
  9. 9.
    Wieling W, van Lieshout JJ (1997) Maintenance of postural normotension in humans. In: Low PA (ed.) Clinical autonomic disorders: evaluation and management. 2nd ed. Philadelphia. Lippincott-Raven, pp 73–82Google Scholar
  10. 10.
    Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, Low PA (1998) A doubleblind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 51(1):120–124PubMedGoogle Scholar

Copyright information

© Steinkopff Verlag 2005

Authors and Affiliations

  • Paola Sandroni
    • 1
  • Tonette L. Opfer-Gehrking
    • 1
  • Wolfgang Singer
    • 1
  • Phillip A. Low
    • 1
  1. 1.Autonomic Disorders CenterMayo ClinicRochester (MN)USA

Personalised recommendations